Sign inGet started

Firuta Paul E

Insider CIK 1602727 · ACHN EVP, Chief Commercial Officer · QURE Chief Commercial Officer · NPSP President, US Comm Operations

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ACHN ACHILLION PHARMACEUTICALS D To issuer deriv2020-01-282020-01-29200,000— $00SEC↗
ACHN ACHILLION PHARMACEUTICALS D To issuer deriv2020-01-282020-01-29400,000— $00SEC↗
ACHN ACHILLION PHARMACEUTICALS A Award deriv2019-01-232019-01-25200,000— $0200,000SEC↗
ACHN ACHILLION PHARMACEUTICALS A Award deriv2018-09-112018-09-12400,000— $0400,000SEC↗
QURE uniQure N.V. A Award deriv2018-01-262018-01-3022,843— $022,843SEC↗
QURE uniQure N.V. A Award2018-01-262018-01-308,566— $093,817SEC↗
QURE uniQure N.V. S Sale2018-01-032018-01-035,864$20.13 $118.0K85,251SEC↗
QURE uniQure N.V. A Award2017-12-132017-12-1556,115— $056,115SEC↗
QURE uniQure N.V. A Award deriv2017-01-272017-01-3143,250— $043,250SEC↗
QURE uniQure N.V. A Award deriv2017-01-272017-01-3143,250— $043,250SEC↗
QURE uniQure N.V. A Award deriv2017-01-272017-02-2143,000— $043,000SEC↗
QURE uniQure N.V. A Award deriv2017-01-272017-02-2143,500— $043,500SEC↗
NPSP NPS PHARMACEUTICALS INC D To issuer deriv2015-02-212015-02-2458,421— $00SEC↗
NPSP NPS PHARMACEUTICALS INC D To issuer deriv2015-02-212015-02-2410,905— $00SEC↗
NPSP NPS PHARMACEUTICALS INC D To issuer deriv2015-02-212015-02-2421,386— $00SEC↗
NPSP NPS PHARMACEUTICALS INC U Tender2015-02-212015-02-241,114$46.00 $51.2K0SEC↗
NPSP NPS PHARMACEUTICALS INC A Award deriv2015-02-122015-02-2010,905— $010,905SEC↗
NPSP NPS PHARMACEUTICALS INC A Award deriv2014-04-152014-04-1721,386— $021,386SEC↗
NPSP NPS PHARMACEUTICALS INC A Award deriv2014-04-152014-04-1758,421— $058,421SEC↗